RESEARCH ALERT-Biomarin Pharmaceutical: Leerink Swann raises target price

Nov 19 (Reuters) - BioMarin Pharmaceutical Inc : * Leerink Swann raises target price to $78 from $76; rating outperform For a summary of rating and price target changes on U.S. companies: Reuters Eikon users, click on Reuters 3000Xtra users, double-click Thomson ONE users, type in RT/RCH/US For a summary of rating and price target changes on Canadian companies: Reuters Eikon users, click on Reuters 3000Xtra users, double-click Thomson ONE users, type in RT/RCH/CA